BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for F-star Therapeutics, Inc. (FSTX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for F-star Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-12
8:17 pm
Purchase		 2020-12-31 13G F-star Therapeutics, Inc.
FSTX		 BIOTECHNOLOGY VALUE FUND L P 25,844
1.000%		 25,844increase
(New Position)		 Filing